Nine Masts Capital’s CME Group CME Stock Holding History

Nine Masts Capital’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-200	Closed	-$11K	–	278
2017 Q4	$11K	Buy	+200	New	+$28.5K	﹤0.01%	210

Other funds holding CME

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Nine Masts Capital's CME Position: Q1 2018 in Review

Nine Masts Capital sold out of CME Group (CME) in Q1 2018, closing a stake of 1,370 shares — an estimated $200K sold.

Nine Masts Capital first reported a position in CME in Q4 2017 and held it in 1 quarter. The position peaked at $200K in Q4 2017. 898 funds tracked by Wall St. Rank hold CME as of Q1 2018.

Nine Masts Capital reported no remaining CME Group position as of Q1 2018 after selling out during the quarter.
Nine Masts Capital sold 1,370 CME Group shares in Q1 2018, an estimated $200K.
Nine Masts Capital first reported a position in CME Group in Q4 2017 and held it in 1 quarter.
Nine Masts Capital's CME Group position peaked at $200K in Q4 2017.
898 funds tracked by Wall St. Rank held CME Group as of Q1 2018.

Based on Nine Masts Capital's 13F filing for Q1 2018, filed 14 May 2018.